2005University of North Texas Digital Library (University of North Texas)Open access

Beneficiary Cost-Sharing Under the Medicare Prescription Drug Benefit

Jim Hahn

Open full text 0 citations

Abstract

This report analyzes how the cost-sharing and premium provisions under Part D would affect the amount that a beneficiary would pay annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plan's standard benefit.

About this research paper

What this paper is about

This report analyzes how the cost-sharing and premium provisions under Part D would affect the amount that a beneficiary would pay annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plan's standard benefit.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This report analyzes how the cost-sharing and premium provisions under Part D would affect the amount that a beneficiary would pay annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plan's standard benefit.

Key concepts: Beneficiary, Prescription drug, Cost sharing, Medical prescription, Medicare Part D, Business, Actuarial science, Drug

Related papers

Back to paper searchBrowse research topicsOriginal source
Beneficiary Cost-Sharing Under the Medicare Prescription Drug Benefit — Research Paper | ScholarLens